https://scholars.lib.ntu.edu.tw/handle/123456789/635372
標題: | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data | 作者: | Arber, Daniel A Orazi, Attilio Hasserjian, Robert P Borowitz, Michael J Calvo, Katherine R Kvasnicka, Hans-Michael Wang, Sa A Bagg, Adam Barbui, Tiziano Branford, Susan Bueso-Ramos, Carlos E Cortes, Jorge E Dal Cin, Paola DiNardo, Courtney D Dombret, Hervé Duncavage, Eric J Ebert, Benjamin L Estey, Elihu H Facchetti, Fabio Foucar, Kathryn Gangat, Naseema Gianelli, Umberto Godley, Lucy A Gökbuget, Nicola Gotlib, Jason Hellström-Lindberg, Eva Hobbs, Gabriela S Hoffman, Ronald Jabbour, Elias J Kiladjian, Jean-Jacques Larson, Richard A Le Beau, Michelle M Loh, Mignon L-C Löwenberg, Bob Macintyre, Elizabeth Malcovati, Luca Mullighan, Charles G Niemeyer, Charlotte Odenike, Olatoyosi M Ogawa, Seishi Orfao, Alberto Papaemmanuil, Elli Passamonti, Francesco Porkka, Kimmo Pui, Ching-Hon Radich, Jerald P Reiter, Andreas Rozman, Maria Rudelius, Martina Savona, Michael R Schiffer, Charles A Schmitt-Graeff, Annette Shimamura, Akiko Sierra, Jorge Stock, Wendy A Stone, Richard M Tallman, Martin S Thiele, Jürgen HWEI-FANG TIEN Tzankov, Alexandar Vannucchi, Alessandro M Vyas, Paresh Wei, Andrew H Weinberg, Olga K Wierzbowska, Agnieszka Cazzola, Mario Döhner, Hartmut Tefferi, Ayalew |
公開日期: | 15-九月-2022 | 出版社: | Elsevier B.V. | 卷: | 140 | 期: | 11 | 起(迄)頁: | 1200 | 來源出版物: | Blood | 摘要: | The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. This collaboration was primarily based on input from a clinical advisory committees (CACs) composed of pathologists, hematologists, oncologists, geneticists, and bioinformaticians from around the world. The recent advances in our understanding of the biology of hematologic malignancies, the experience with the use of the 2016 WHO classification in clinical practice, and the results of clinical trials have indicated the need for further revising and updating the classification. As a continuation of this CAC-based process, the authors, a group with expertise in the clinical, pathologic, and genetic aspects of these disorders, developed the International Consensus Classification (ICC) of myeloid neoplasms and acute leukemias. Using a multiparameter approach, the main objective of the consensus process was the definition of real disease entities, including the introduction of new entities and refined criteria for existing diagnostic categories, based on accumulated data. The ICC is aimed at facilitating diagnosis and prognostication of these neoplasms, improving treatment of affected patients, and allowing the design of innovative clinical trials. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/635372 | ISSN: | 00064971 | DOI: | 10.1182/blood.2022015850 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。